ELAN
+4.5%🟢 Fundamentally supportedElanco Animal Health Incorporated Common Stock · Healthcare
What happened
Why it moved
- Q2 Earnings Outperformers: Elanco (NYSE:ELAN) And The Rest Of The Pharmaceuticals Stocks — finnhub-news
Possible catalyst: analyst upgrade, 2.6pp above its sector.
Verdict — was the move justified?
🟢 Fundamentally supported
Analyst upgrade — direction and rough magnitude are consistent with the identified fundamental catalyst.
How unusual is this move
Today’s move is among the largest 7% of ELAN’s daily moves over the last 5 years — while the sector moved +1.9% and the market +1.1%.
What happened after similar moves
109 similar up moves in ELAN’s 5-year history:
Median of same-direction moves within ±35% magnitude band. Past patterns don’t predict outcomes — context, not signal.
Fundamental context
Insider activity (90d): net buying $1.03M
Valuation context
Trading richer than 86% of its own historical valuation range.
Full fundamental analysis on PreMarketPrice
Pillar scores, financial statements, valuation history, news & more for ELAN